About us

AtG Therapeutics is a pre-clinical stage drug development company specialized in the discovery of targets of metabolic adaptation and the development of therapeutics and biomarkers to treat advanced cancer.

Our vision is to build a pipeline of metabolic adaptation inhibitors allowing patients to sustain cancer starvation over time

Metabolic Adaptation is Essential for Cancer 

Metabolic adaptation is a hallmark of cancer1

Ensures supply of nutrients to cancer cells

Enables them to grow aggressively and resist to therapy

1. D. Hanahan, Cell (2011) & Cancer Discovery (2022)

Technology

The science is based on our unique ability to design and develop strategies that selectively target and eliminate cancer cells metabolically adapted and a plasma biomarker able to identify who would be benefit from the target inhibition.

Recognition

The novelty and the potential impact of the AtG project has been recognized by several entities at a national and international level.

European Research Council (ERC)

Learn more